Published in Volume
102, Issue 8 (October 15, 1998)
J Clin Invest. 1998;102(8):1469–1472.
doi:10.1172/JCI4461.
Copyright ©
1998, The American Society for
Clinical Investigation.
Research Article
Chemokines activate Kaposi's sarcoma-associated herpesvirus G protein-coupled receptor in mammalian cells in culture.
M C Gershengorn, E Geras-Raaka, A Varma and I Clark-Lewis
Division of Molecular Medicine, Department of Medicine, Cornell University Medical College and The New York Hospital, New York 10021, USA. mcgersh@mail.med.cornell.edu
Published October 15, 1998
Kaposi's sarcoma-associated herpesvirus (KSHV)/human herpesvirus 8, a virus that appears to be involved in the pathogenesis of Kaposi's sarcoma and primary effusion lymphomas, encodes a G protein-coupled receptor (KSHV-GPCR) that exhibits constitutive signaling. In this report, we show that two chemokines, interleukin 8 (IL-8) and growth-related protein-alpha, activate KSHV-GPCR over constitutive levels. Moreover, as with human receptors, the integrity of the ELR motif of these chemokines is required for activation of KSHV-GPCR. Other residues that are required for IL-8 binding to human chemokine receptors CXCR1 and CXCR2 are important for KSHV-GPCR activation also. Thus, it appears that the ELR binding site and other key domains of ELR chemokine activation have been preserved in the virus KSHV-GPCR. The results suggest that KSHV-GPCR originated from CXCR1 or CXCR2 and that activation of KSHV-GPCR by endogenous chemokines may affect the pathobiology of KSHV infection in humans.